Japan · Delayed Price · Currency is JPY MT Genex Statistics
Total Valuation
MT Genex has a market cap or net worth of JPY 3.91 billion. The enterprise value is 2.00 billion.
| Market Cap | 3.91B |
| Enterprise Value | 2.00B |
Important Dates
The next confirmed earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
MT Genex has 1.08 million shares outstanding.
| Current Share Class | 1.08M |
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 5.48% |
| Owned by Institutions (%) | 1.11% |
| Float | 259,266 |
Valuation Ratios
The trailing PE ratio is 12.44.
| PE Ratio | 12.44 |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | 72.35 |
| P/OCF Ratio | 51.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.74, with an EV/FCF ratio of 36.98.
| EV / Earnings | 6.36 |
| EV / Sales | 0.42 |
| EV / EBITDA | 3.74 |
| EV / EBIT | 4.30 |
| EV / FCF | 36.98 |
Financial Position
The company has a current ratio of 5.88, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.88 |
| Quick Ratio | 3.48 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 1.54 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.36% and return on invested capital (ROIC) is 12.62%.
| Return on Equity (ROE) | 7.36% |
| Return on Assets (ROA) | 5.39% |
| Return on Invested Capital (ROIC) | 12.62% |
| Return on Capital Employed (ROCE) | 9.72% |
| Weighted Average Cost of Capital (WACC) | 5.35% |
| Revenue Per Employee | 31.22M |
| Profits Per Employee | 2.08M |
| Employee Count | 134 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 249.45 |
Taxes
In the past 12 months, MT Genex has paid 176.00 million in taxes.
| Income Tax | 176.00M |
| Effective Tax Rate | 35.92% |
Stock Price Statistics
The stock price has increased by +21.08% in the last 52 weeks. The beta is 0.22, so MT Genex's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +21.08% |
| 50-Day Moving Average | 3,541.40 |
| 200-Day Moving Average | 3,523.13 |
| Relative Strength Index (RSI) | 59.19 |
| Average Volume (20 Days) | 535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MT Genex had revenue of JPY 4.71 billion and earned 314.00 million in profits. Earnings per share was 291.82.
| Revenue | 4.71B |
| Gross Profit | 1.10B |
| Operating Income | 464.00M |
| Pretax Income | 490.00M |
| Net Income | 314.00M |
| EBITDA | 534.00M |
| EBIT | 464.00M |
| Earnings Per Share (EPS) | 291.82 |
Balance Sheet
The company has 1.99 billion in cash and 83.00 million in debt, with a net cash position of 1.91 billion or 1,774.65 per share.
| Cash & Cash Equivalents | 1.99B |
| Total Debt | 83.00M |
| Net Cash | 1.91B |
| Net Cash Per Share | 1,774.65 |
| Equity (Book Value) | 4.40B |
| Book Value Per Share | 4,088.21 |
| Working Capital | 4.25B |
Cash Flow
In the last 12 months, operating cash flow was 76.00 million and capital expenditures -22.00 million, giving a free cash flow of 54.00 million.
| Operating Cash Flow | 76.00M |
| Capital Expenditures | -22.00M |
| Depreciation & Amortization | 70.00M |
| Net Borrowing | -17.00M |
| Free Cash Flow | 54.00M |
| FCF Per Share | 50.17 |
Margins
Gross margin is 23.27%, with operating and profit margins of 9.84% and 6.66%.
| Gross Margin | 23.27% |
| Operating Margin | 9.84% |
| Pretax Margin | 10.39% |
| Profit Margin | 6.66% |
| EBITDA Margin | 11.33% |
| EBIT Margin | 9.84% |
| FCF Margin | 1.15% |
Dividends & Yields
This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 1.10%.
| Dividend Per Share | 40.00 |
| Dividend Yield | 1.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.38% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.08% |
| Earnings Yield | 8.04% |
| FCF Yield | 1.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2017. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
MT Genex has an Altman Z-Score of 4.54 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.54 |
| Piotroski F-Score | 5 |